Controversies in PE: Who and When to Treat, and How?

Coordinator(s)

• 

  Vivian Bishay, MD

  Associate Professor
  Icahn School of Medicine at Mount Sinai Hospital, United States
• 

  Akhilesh Sista, MD

  Professor
  Weill Cornell Medicine, United States

Presentations:

• 4:15 PM – 4:25 PM CT

  Improvements in predicting decompensation for the acute PE patient: prediction models for risk stratification
  

  Speaker: Ripal Gandhi, MD, FSIR – Miami Cardiac & Vascular Institute, Miami Cancer Institute
• 4:25 PM – 4:35 PM CT

  Complex PE cases: pert decision making with a focus on special populations (eg pregnancy, cancer, acute on chronic PE)
  

  Speaker: Edwin A. Takahashi, MD – Mayo Clinic
• 4:35 PM – 4:45 PM CT

  AI to improve PE outcomes: current and future applications
  

  Speaker: Dan Shilo, MD – Mount Sinai
• 4:45 PM – 4:55 PM CT

  Device selection: lytic vs non vs combination therapies
  

  Speaker: Christopher Harnain, MD, MBA, RPVI – Division IR Weill Cornell Medical Center
• 4:55 PM – 5:05 PM CT

  Endovascular therapy endpoints: what guides our decision making and what does the data support?
  

  Speaker: Vivian Bishay, MD – Icahn School of Medicine at Mount Sinai Hospital
• 5:05 PM – 5:15 PM CT

  The post PE RCT world: what will we know?
  

  Speaker: Bedros Taslakian, MD, MA (he/him/his) – NYU Langone Health
• 5:15 PM – 5:30 PM CT

  Q&A